Email Us! Facebook Facebook You Tube Join Now
(309) 663-6497

SLOW BIOTECH APPROVAL COST U.S. $7 BILLION –

SLOW BIOTECH APPROVAL COST U.S. $7 BILLION – According to CropLife International, delays in Chinese approvals of imported GM crops have cut U.S. GDP by about $7 billion over the past five years by reducing sales of crops and other goods. Throughout trade talks with the country, the U.S. has asked Chinese officials to speed up its approval process and grant wider access for GM crops. (Reuters)

This entry was posted in Agriculture News. Bookmark the permalink. Both comments and trackbacks are currently closed.